{"id":42540,"date":"2018-11-29T12:10:10","date_gmt":"2018-11-29T10:10:10","guid":{"rendered":"https:\/\/newserver.fyb.de\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/"},"modified":"2018-11-29T12:10:10","modified_gmt":"2018-11-29T10:10:10","slug":"idinvest-partners-7-million-euro-series-a-for-teleclinic","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/","title":{"rendered":"Idinvest Partners: 7 million Euro Series\u2011A for TeleCLinic"},"content":{"rendered":"<p>Munich \/ Frank\u00adfurt am Main \u2014 Munich-based <strong>tele\u00adme\u00addi\u00adcine company Tele\u00adCli\u00adnic<\/strong> has successfully closed its Series A finan\u00adcing and recei\u00adved a capi\u00adtal commit\u00adment of seven million euros from <strong>Idin\u00advest Part\u00adners<\/strong> to expand its market leader\u00adship in telemedicine.<\/p>\n<p>Idin\u00advest Part\u00adners is a Euro\u00adpean invest\u00adment company specia\u00adli\u00adzing in the SME segment, with more than eight billion euros in assets under manage\u00adment, which has alre\u00adady comple\u00adted more than 4,000 finan\u00adcings throug\u00adhout Europe. As one of the largest Euro\u00adpean venture capi\u00adtal inves\u00adtors, Idin\u00advest Part\u00adners is able to support port\u00adfo\u00adlio compa\u00adnies from seed finan\u00adcing to later finan\u00adcing stages. The company has previously funded digi\u00adtal pioneers such as Allt\u00adhings, Deezer, Wefox and Withings.<\/p>\n<p>Just in Novem\u00adber 2017, Tele\u00adCli\u00adnic had closed a seed finan\u00adcing of two million euros. Now the next big step is about to be taken to scale the busi\u00adness model and provide digi\u00adtal access to medi\u00adcal care for milli\u00adons more pati\u00adents. New stra\u00adte\u00adgic part\u00adner\u00adships and marke\u00adting measu\u00adres are plan\u00adned for this purpose.<\/p>\n<p>Today, 50 percent of all private pati\u00adents in Germany alre\u00adady have free digi\u00adtal access to doctors from 30 special\u00adties thanks to Tele\u00adCli\u00adnic. The number of people with statu\u00adtory health insu\u00adrance is around nine million. This makes Tele\u00adCli\u00adnic part of stan\u00addard care. For private pati\u00adents, e\u2011prescriptions are possi\u00adble throug\u00adhout Germany via Tele\u00adCli\u00adnic. For this purpose, the company coope\u00adra\u00adtes with 7,000 phar\u00admacies. Those with statu\u00adtory health insu\u00adrance are to follow suit in 2019 \u2014 initi\u00adally as part of a pilot project. Medi\u00adcal services are available seven days a week, around the clock, and on holidays.<\/p>\n<p>With annual growth of 3.8 percent, the health\u00adcare sector is growing signi\u00adfi\u00adcantly faster than the gross dome\u00adstic product (source: BMWI Gesund\u00adheits\u00adwirt\u00adschaft Zahlen und Fakten 2016). The health\u00adcare indus\u00adtry is thus a growth sector that is not depen\u00addent on econo\u00admic cycles. The private sector, for exam\u00adple medi\u00adcal products or e\u2011health appli\u00adca\u00adti\u00adons, accounts for 21.3 percent of value added. Tele\u00adme\u00addi\u00adcine is seen as a promi\u00adsing future market.<\/p>\n<p><strong>Katha\u00adrina J\u00fcnger (photo) , CEO of Tele\u00adCli\u00adnic<\/strong>is convin\u00adced that tele\u00adme\u00addi\u00adcine will play a central role in the German health\u00adcare system in the future: \u201cThe digi\u00adtiza\u00adtion of the health\u00adcare system is curr\u00adently advan\u00adcing in leaps and bounds. We are actively helping to shape this deve\u00adlo\u00adp\u00adment and want to use Tele\u00adCli\u00adnic to ensure digi\u00adtal access to high-quality primary care across the coun\u00adtry. Germany needs tele\u00adme\u00addi\u00adcine to effi\u00adci\u00adently meet chal\u00adlenges such as demo\u00adgra\u00adphic change. People are getting older and, as a result, spen\u00adding is rising. Tele\u00adcon\u00adsul\u00adta\u00adtion alone has an esti\u00adma\u00adted bene\u00adfit poten\u00adtial of 4.4 billion euros. We are plea\u00adsed to have gained a strong part\u00adner in Idin\u00advest Part\u00adners to digi\u00adtally shape the future of health.\u201d<\/p>\n<p>Matthieu Baret, Mana\u00adging Part\u00adner at Idin\u00advest Part\u00adners and respon\u00adsi\u00adble for Venture and Growth Capi\u00adtal, said: \u201cIdin\u00advest Part\u00adners has made a name for itself as one of the highest-profile venture capi\u00adtal inves\u00adtors in Europe with invest\u00adments in well-known and successful compa\u00adnies in the digi\u00adtal and health\u00adcare indus\u00adtries. The invest\u00adment in Tele\u00adCli\u00adnic repres\u00adents another mile\u00adstone in this stra\u00adtegy. Tele\u00adCli\u00adnic is a pioneer in a promi\u00adsing busi\u00adness area and a market with great poten\u00adtial. In an envi\u00adron\u00adment of demo\u00adgra\u00adphic change and incre\u00adasing gaps in medi\u00adcal care in rural areas, the company fulfills an important social mission. We are plea\u00adsed to support Tele\u00adCli\u00adnic in fulfil\u00adling this mission.\u201d<\/p>\n<p><strong>About Tele\u00adCli\u00adnic<\/strong><br>\nTele\u00adCli\u00adnic is a digi\u00adtal health plat\u00adform and first point of cont\u00adact for people who have ques\u00adti\u00adons about their health. The Tele\u00adCli\u00adnic physi\u00adci\u00adans are available for pati\u00adents seven days a week and at any time of day \u2014 without long waiting times. Only physi\u00adci\u00adans with a German license to prac\u00adtice medi\u00adcine are admit\u00adted to Tele\u00adCli\u00adnic. Medi\u00adcal consul\u00adta\u00adtion takes place via modern and nowa\u00addays common commu\u00adni\u00adca\u00adtion chan\u00adnels. The pati\u00adent can choose whether the doctor\u2019s conver\u00adsa\u00adtion takes place via video chat or on the phone, for exam\u00adple. Tele\u00adCli\u00adnic is also a digi\u00adtal pioneer in the area of e\u2011prescription: e\u2011prescriptions have been possi\u00adble for priva\u00adtely insu\u00adred pati\u00adents since the begin\u00adning of 2018. To this end, the company coope\u00adra\u00adtes with 7,000 phar\u00admacies in private prac\u00adtice. To ensure that pati\u00adents can use the services of the Tele\u00adCli\u00adnic free of charge, the company coope\u00adra\u00adtes with various payers. Curr\u00adently, eight private health insu\u00adr\u00aders and four statu\u00adtory health insu\u00adr\u00aders coope\u00adrate with Tele\u00adCli\u00adnic. In addi\u00adtion, as part of the coope\u00adra\u00adtion with the Asso\u00adcia\u00adtion of Statu\u00adtory Health Insu\u00adrance Physi\u00adci\u00adans in Baden-W\u00fcrt\u00adtem\u00adberg, all statu\u00adtory health insu\u00adrance funds in Baden-W\u00fcrt\u00adtem\u00adberg bear the costs for digi\u00adtal health services via the Tele\u00adCli\u00adnic infrastructure.<\/p>\n<p>Data secu\u00adrity is a top prio\u00adrity: the Tele\u00adCli\u00adnic app ther\u00ade\u00adfore complies with the requi\u00adre\u00adments of the Medi\u00adcal Devices Act for CE certi\u00adfi\u00adca\u00adtion. Tele\u00adCli\u00adnic\u2019s mission is to deve\u00adlop digi\u00adtal and effi\u00adci\u00adent alter\u00adna\u00adti\u00adves for the German health\u00adcare system that bene\u00adfit pati\u00adents, insu\u00adrance compa\u00adnies, health insu\u00adr\u00aders and doctors. www.teleclinic.com<\/p>\n<p><strong>About Idin\u00advest Partners<\/strong><br>\nIdin\u00advest Part\u00adners is a leading Euro\u00adpean invest\u00adment firm focu\u00adsed on the mid market. Curr\u00adently, Idin\u00advest Part\u00adners mana\u00adges assets of around \u20ac8 billion with more than 90 employees and has offices in Paris, Frank\u00adfurt, Madrid, Shang\u00adhai and Dubai. The company has three busi\u00adness units: Venture &amp; Growth Capi\u00adtal, Private Debt and Private Funds Group. The company was foun\u00added in 1997 as part of the Alli\u00adanz Group and has been inde\u00adpen\u00addent since 2010. In Janu\u00adary 2018, Idin\u00advest Part\u00adners merged with Eura\u00adzeo. The merger has crea\u00adted a leading invest\u00adment company in Europe and North America with 15 billion euros in assets under management.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Munich \/ Frank\u00adfurt am Main \u2014 Munich-based tele\u00adme\u00addi\u00adcine company Tele\u00adCli\u00adnic has successfully closed its Series A finan\u00adcing and recei\u00adved a capi\u00adtal commit\u00adment of seven million euros from Idin\u00advest Part\u00adners to expand its market leader\u00adship in tele\u00adme\u00addi\u00adcine. Idin\u00advest Part\u00adners is a Euro\u00adpean invest\u00adment company specia\u00adli\u00adzing in the SME segment, with more than eight billion euros&nbsp;in&nbsp;[\u2026]<\/p>\n","protected":false},"author":2,"featured_media":42549,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1366],"tags":[],"class_list":["post-42540","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-news-en","news-category-venture-capital-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Idinvest Partners: 7 million Euro Series-A for TeleCLinic - FYB Financial Yearbook<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Idinvest Partners: 7 million Euro Series-A for TeleCLinic - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Munich \/ Frank\u00adfurt am Main \u2014 Munich-based tele\u00adme\u00addi\u00adcine company Tele\u00adCli\u00adnic has successfully closed its Series A finan\u00adcing and recei\u00adved a capi\u00adtal commit\u00adment of seven million euros from Idin\u00advest Part\u00adners to expand its market leader\u00adship in telemedicine. Idin\u00advest Part\u00adners is a Euro\u00adpean invest\u00adment company specia\u00adli\u00adzing in the SME segment, with more than eight billion euros in [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2018-11-29T10:10:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/11\/a-k-jucc88nger-e1543486178119.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"225\" \/>\n\t<meta property=\"og:image:height\" content=\"208\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"Idinvest Partners: 7 million Euro Series\u2011A for TeleCLinic\",\"datePublished\":\"2018-11-29T10:10:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/\"},\"wordCount\":863,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/11\/a-k-jucc88nger-e1543486178119.jpeg\",\"articleSection\":[\"General\",\"Featured\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/\",\"url\":\"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/\",\"name\":\"Idinvest Partners: 7 million Euro Series-A for TeleCLinic - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/11\/a-k-jucc88nger-e1543486178119.jpeg\",\"datePublished\":\"2018-11-29T10:10:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/11\/a-k-jucc88nger-e1543486178119.jpeg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/11\/a-k-jucc88nger-e1543486178119.jpeg\",\"width\":225,\"height\":208},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Idinvest Partners: 7 million Euro Series\u2011A for TeleCLinic\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Idinvest Partners: 7 million Euro Series-A for TeleCLinic - FYB Financial Yearbook","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/","og_locale":"en_US","og_type":"article","og_title":"Idinvest Partners: 7 million Euro Series-A for TeleCLinic - FYB Financial Yearbook","og_description":"Munich \/ Frank\u00adfurt am Main \u2014 Munich-based tele\u00adme\u00addi\u00adcine company Tele\u00adCli\u00adnic has successfully closed its Series A finan\u00adcing and recei\u00adved a capi\u00adtal commit\u00adment of seven million euros from Idin\u00advest Part\u00adners to expand its market leader\u00adship in telemedicine. Idin\u00advest Part\u00adners is a Euro\u00adpean invest\u00adment company specia\u00adli\u00adzing in the SME segment, with more than eight billion euros in [&hellip;]","og_url":"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2018-11-29T10:10:10+00:00","og_image":[{"width":225,"height":208,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/11\/a-k-jucc88nger-e1543486178119.jpeg","type":"image\/jpeg"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"Idinvest Partners: 7 million Euro Series\u2011A for TeleCLinic","datePublished":"2018-11-29T10:10:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/"},"wordCount":863,"commentCount":0,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/11\/a-k-jucc88nger-e1543486178119.jpeg","articleSection":["General","Featured","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/","url":"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/","name":"Idinvest Partners: 7 million Euro Series-A for TeleCLinic - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/11\/a-k-jucc88nger-e1543486178119.jpeg","datePublished":"2018-11-29T10:10:10+00:00","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/11\/a-k-jucc88nger-e1543486178119.jpeg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/11\/a-k-jucc88nger-e1543486178119.jpeg","width":225,"height":208},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/idinvest-partners-7-million-euro-series-a-for-teleclinic\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"Idinvest Partners: 7 million Euro Series\u2011A for TeleCLinic"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/42540","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=42540"}],"version-history":[{"count":0,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/42540\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/42549"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=42540"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=42540"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=42540"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}